Total Cost Management

Total cost management momentum is shifting toward more operationally specific levers: CJR-X is pushing health systems to use episode-level analytics for orthopedic spend, post-acute utilization, and reconciliation performance, while payer-provider risk discussions increasingly hinge on whether plans will bring clinical teams and actionable data to reduce low-value and avoidable care—not just transfer downside risk to providers (CJR-X data strategies; HFMA payer risk dynamics). At the same time, HHS OIG scrutiny of high Medicare Advantage prior authorization denials for LTAC and inpatient rehab by the largest MA insurers is sharpening the tension between payer cost control and provider-led care management, especially for ACOs and health systems accountable for total cost and outcomes across post-acute transitions. Trump administration signals from CMS leadership, including Administrator Dr. Mehmet Oz, suggest continued interest in innovation and cost discipline, but VBC stakeholders should expect tighter scrutiny of whether utilization management, obesity/GLP-1 strategies, and risk contracts produce measurable savings without undermining access.